Normal human cells exhibit a limited capacity for division (senescence) in vitro, in contrast to tumor-derived and virusor carcinogen-transformed cells, which can divide indefinitely (immortal) (11, 12) . A number of recent studies have suggested that senescent cells produce a membraneassociated protein inhibitor(s) of the initiation of DNA synthesis that is not present in young proliferating cells; production of this protein inhibitor(s) might be involved in senescence (4, 7, 23) . Cell hybrid studies have shown that the phenotype of senescence is dominant over that of cellular immortality (24, 26) . Therefore, an altered regulation of the expression of the senescence inhibitor protein(s) or modifications of the protein(s) itself might result in cellular immortality. Cellular proto-oncogene and oncogene proteins have been clearly demonstrated to be positive regulators of cell growth and are potential candidates for initiators of DNA synthesis that could act antagonistically to the inhibitor(s) in senescent cells (2, 13) . Since the H-ras product acts at the membrane of cells, as does the putative senescence protein(s) (29, 36) , we tested the ability of cloned c-H-ras DNAs to functionally reverse inhibitor activity after microinjection into senescent cells. Normal young cells that have been made nonproliferating (quiescent) by the reduction of serum growth factors also produce a membraneassociated protein inhibitor(s) of the initiation of DNA synthesis (3, 23) . Therefore, the effect of microinjected c-H-ras DNA in these cells was tested as well.
Two human cell lines were used as recipients of the microinjected DNA in this study. CSC303 is a diploid fibroblast line which was derived from neonatal foreskin and has a total in vitro life span of 80 population doublings (25) . CSC301 is a diploid fibroblast line which was derived from fetal lung and has a total in vitro life span of 100 population doublings (8) . Cultures were considered to be senescent when they did not reach confluence within 4 weeks after subculturing and had a labeling index of <1%. Quiescent cells were obtained from cultures having at least 50 population doublings remaining.
For microinjection, the cells were plated at a density of 5 x l03 per 35-mm dish onto glass cover slips (22-mm square) into which 3-mm-diameter circles had been etched with a diamond pencil; the cells were allowed to attach in Eagle minimal essential medium plus 10% fetal bovine serum.
Senescent cells and cells made quiescent by contact inhibition were maintained in this medium for the duration of the experiment. The cells to be made quiescent by serum deprivation were washed with buffered saline 24 h after being plated and were maintained for at least 10 days in Eagle minimal essential medium plus 0.5% fetal bovine serum (6) . Microinjection was performed as described in detail previously (19) . At least 200 cells were microinjected per experiment. Tritiated thymidine (0.1 jxCi/ml) was then added to the cells. The cells were incubated for appropriate intervals (48 h for senescent cells, 30 h for quiescent cells) and then processed for autoradiography (31) . For analysis, cells within the circle (injected) and peripheral to the circle (uninjected) were examined. Within each category the cells whose nuclei contained >10 silver grains were counted as labeled. All microinjected cells and at least 300 uninjected cells were analyzed. The results are the average of two or more independent experiments.
Initially, the effect of the oncogene form of c-H-ras DNA was examined. Cloned DNA isolated from the bladder carcinoma cell line EJ (30) It is known that the oncogene form (T24) of the ras product has a reduced GTPase activity relative to the proto-oncogene form (P3) (33) . This reduction in enzyme activity correlates with the ability of the p21(T24) protein to stimulate DNA synthesis and to induce morphological changes in rodent (REF 52 or NIH 3T3) cells at concentrations at which the normal p21(P3) protein has no effect (9) . However, the cells used in this study responded equally well to the proto-oncogene and oncogene c-H-ras DNAs, indicating that the mitogenic activities of the products in human fibroblasts do not correlate with the levels of GTPase activity. Recent observations by Lacal et al. (15) have suggested that the transforming activity of ras proteins can occur by mechanism(s) other than reduction in GTPase activity.
Other laboratories have demonstrated the need for two oncogenes working in concert to convert primary rodent cells to tumorigenic cells. Oncogenes that have been shown to complement H-ras in this process are polyomavirus T antigen, the ElA region of the adenovirus genome, and c-myc (16, 21, 27) . We tested the hypothesis that a combination of complementary oncogenes may be necessary to stimulate DNA synthesis in senescent cells. A plasmid carrying the adenovirus ElA gene (pAdl2E1A, kindly provided by R. Bernards [1] ) was coinjected with the oncogene form of c-H-ras (pT24) into senescent cells ( Table 2 ). The cells did not incorporate tritiated thymidine, indicating that senescent normal human cells do not respond to the mitogenic effects of a combination of oncogenes that is able to permit transformation and tumorigenic progression in primary rodent cells.
This lack of response of senescent cells to microinjected oncogenes is not due to an increased sensitivity to microinjection or to an absolute inability of the cells to synthesize DNA following any stimulus. Senescent cells can The lack of response of senescent cells to microinjected oncogenes could be due to the fact that high-abundance antiproliferative mRNAs are present in these cells (18) . These mRNAs probably code for a protein inhibitor(s) of DNA synthesis that is expressed in senescent cells (4, 7, 23 ). Sager and co-workers (5, 28) have proposed the existence of anti-oncogenes in normal cells that suppress the action of the oncogene protein products. We consider the senescent-cell inhibitor to be a prime candidate for an anti-oncogene.
These results emphasize the marked difference in response to the introduction of exogenous DNA between human and rodent cells. This study clearly shows that human cells are highly refractory to changes in the mechanisms that limit their in vitro life span. This is in agreement with the finding that the frequency of immortalization of human cells in culture is very low.
